Valion Bio, Inc. VBIO
At closeNov 11, 2026, 5:00 PM EST
After hours · Nov 11, 5:00 PM ET
- YTD
- -98.61%
- 1 year
- -99.11%
VBIO free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-7,037,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | -7,037,000 | -1,312,000 | Not meaningful |
| FY 2024 | 2024-12-31 | -5,725,000 | 2,904,000 | Not meaningful |
| FY 2023 | 2023-12-31 | -8,629,000 | 301,000 | Not meaningful |
| FY 2022 | 2022-12-31 | -8,930,000 | -3,318,000 | Not meaningful |
| FY 2021 | 2021-12-31 | -5,612,000 | -2,585,000 | Not meaningful |
| FY 2020 | 2020-12-31 | -3,027,000 | 674,000 | Not meaningful |
| FY 2019 | 2019-12-31 | -3,701,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-09-01T06:02:14.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.